Complement C1 Inactivator Proteins [clinicaltrials_resource:d9e5c26ff6e5061202b50cdcebb4b8ec]
clinicaltrials:NCT00225147Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema [clinicaltrials:NCT00261053]Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema [clinicaltrials:NCT00262288]clinicaltrials:NCT00262301clinicaltrials:NCT00289211clinicaltrials:NCT00292981Pharmacokinetics of C1 Esterase Inhibitor in Hereditary Angioedema Subjects [clinicaltrials:NCT00432510]clinicaltrials:NCT00438815clinicaltrials:NCT00462709clinicaltrials:NCT00748202In Vivo Effects of C1-esterase Inhibitor on the Innate Immune Response During Human Endotoxemia [clinicaltrials:NCT00785018]clinicaltrials:NCT00851409clinicaltrials:NCT01005888Recombinant Human C1 Inhibitor for the Treatment of Early Antibody-Mediated Rejection in Renal Transplantation [clinicaltrials:NCT01035593]Patient Registry Study of Berinert® in Normal Clinical Practice [clinicaltrials:NCT01108848]clinicaltrials:NCT01134510clinicaltrials:NCT01147302C1-INH Compared to Placebo at the Time of Prodromal Symptoms for Hereditary Angioedema (HAE) Exacerbation [clinicaltrials:NCT01151735]clinicaltrials:NCT01275976clinicaltrials:NCT01426763A Study to Evaluate the Clinical Pharmacology and Safety of C1-esterase Inhibitor Administered by the Subcutaneous Route [clinicaltrials:NCT01576523]clinicaltrials:NCT01756157clinicaltrials:NCT01759602A Study to Evaluate the Safety and Pharmacokinetics of Two Formulations of C1-esterase Inhibitor [clinicaltrials:NCT01760343]In Vivo Effects of C1-esterase Inhibitor on the Innate Immune Response During Human Endotoxemia - VECTOR II [clinicaltrials:NCT01766414]A Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema [clinicaltrials:NCT01912456]Safety and Efficacy Study of CINRYZE for Prevention of Angioedema Attacks in Children Ages 6-11 With Hereditary Angioedema [clinicaltrials:NCT02052141]clinicaltrials:NCT02134314clinicaltrials:NCT02247739A Study to Evaluate the Long-term Clinical Safety and Efficacy of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema [clinicaltrials:NCT02316353]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Complement C1 Inactivator Proteins [clinicaltrials_resource:d9e5c26ff6e5061202b50cdcebb4b8ec]
Bio2RDF identifier
d9e5c26ff6e5061202b50cdcebb4b8ec
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:d9e5c26ff6e5061202b50cdcebb4b8ec
identifier
clinicaltrials_resource:d9e5c26ff6e5061202b50cdcebb4b8ec
title
Complement C1 Inactivator Proteins
@en
type
label
Complement C1 Inactivator Prot ...... 5c26ff6e5061202b50cdcebb4b8ec]
@en